This analysis showed a significantly lower AMS-C score ( 0.38 ; 95 % CI , 0.21 to 0.54 ) vs 1.10 ; 95 % CI , 0.57 to 1.62 ; P = .04 ) and lower Lake Louise Score ( 3.1 ; 95 % CI , 2.2 to 4.1 vs 5.1 ; 95 % CI , 3.6 to 6.6 ; P = .07 ) for the treatment subgroup .